Latest Breaking News On - Atest astrazeneca pharma q2 earnings updates - Page 1 : comparemela.com

The stock slipped amid reports of the Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, facing a legal challenge the UK

City ofUnited kingdomHooi bien chuahNational stock exchangeAstrazeneca plcHigh courtAstrazeneca pharma indiaAdditional directorAsia area legal directorUnited kingdom basedVaccine induced immune thrombocytopeniaZeneca pharma indiaAstrazeneca pharma q2 earningsStrazeneca pharma q2 earnings newsAtest astrazeneca pharma q2 earnings updatesStrazeneca pharma q2 earnings latest news